ARRY

Good-pond (US utility-scale solar additions at a structural high: EIA projects 43+ GW in 2026, 60% YoY increase), mid-fish (number-two in the US behind Nextracker/Nextpower, which is 2-3x larger in revenue and commands structurally higher margins). ARRY's domestic-content moat and Albuquerque manufacturing are genuine differentiators within the pond; the gap to the category leader on margin and international scale is real and not yet closing.

Snapshot

What It Does

Array Technologies makes single-axis solar trackers — the motorized steel racking systems and control software that rotate utility-scale solar panels to follow the sun throughout the day, improving energy yield by 15-25% versus fixed-tilt installations. The company sells two primary products:

• DuraTrack: The flagship tracker line, manufactured 100% domestically at an Albuquerque, NM facility opened April 2024. Available with US-manufactured torque tubes and structural hardware that qualifies for the IRA domestic content adder.
• OmniTrack: A terrain-following variant designed for uneven ground, currently the highest-share product in the orderbook. Enhanced version (2-degree inter-post flex) shipping Q3 2026.
• SmarTrack software: Patented control software that optimizes panel angle in real time.

Customers are utility-scale solar project developers and independent power producers, predominantly in the US. The 2025 acquisition of APA Solar ($179M, closed during 2025) expanded ARRY into engineered foundations and fixed-tilt systems and added international exposure.

ARRY is the number-two player in the US tracker market behind Nextracker (now Nextpower), which has approximately 2-3x ARRY's revenue and structurally higher margins.

What It's Planning

Management's stated priorities per Q1 2026 commentary and filings:

1. Revenue ramp: Q2 2026 guided $300-320M vs $223.4M in Q1 — a 35-43% sequential step-up, putting 2026 on track at or above the full-year implied run-rate.
2. Domestic content leadership: Leverage the Albuquerque facility to capture the growing IRA domestic content adder market as thresholds escalate to 50% in 2026 and 55% post-2026.
3. International expansion via D2S and APA Solar: DuraTrack D2S (dual-row, international-optimized) in launch phase; APA Solar orderbook grew ~50% in Q1 2026.
4. Full-year 2026 adjusted EBITDA guidance: $200-$230M (midpoint $215M) — a step-up from prior years, dependent on revenue conversion at 30%+ adjusted gross margins.
5. 45X credit capture: Continue recognizing the 45X Advanced Manufacturing Production Credit on domestically manufactured torque tubes and structural fasteners, a direct gross margin tailwind.

Catalysts & Demand Drivers

Near-term:

1. Q2 2026 earnings (early August 2026) — $300-320M revenue guidance vs $223.4M in Q1; adjusted gross margin hold at 30%+; any beat-and-raise with 16.7% short interest creates asymmetric upside from short covering.
2. OmniTrack enhanced version shipping (Q3 2026) — doubled terrain-following capability; OmniTrack is already the highest orderbook-share product.
3. DuraTrack D2S international launch (2026) — addresses ARRY's prior international underperformance with a purpose-built product.
4. Treasury domestic content safe harbor tables (by Dec 31, 2026) — statutory deadline; favorable guidance accelerates orderbook conversion by customers finalizing domestic-content sourcing.

Structural: 5. US utility-scale solar supercycle — EIA projects 43.4 GW new capacity in 2026 alone (+60% YoY), nearly 70 GW across 2026-2027. 6. Data-center electricity demand — EIA identifies 2026-2029 as the strongest four-year US electricity demand growth period since 2000; hyperscalers are the primary solar PPA signatories. 7. Domestic content moat compounding — IRA thresholds escalate from 40% to 50% to 55%; ARRY's Albuquerque facility delivers 100% domestic content; rivals without US manufacturing face progressive exclusion.

Track Record

Income statement (SEC EDGAR XBRL, all figures verified from fact sheet):

Revenue swings are wide: a +92% surge from 2020 to 2022 was followed by a -44% collapse from peak 2022 to the 2024 trough, then a 40% rebound in 2025. GAAP operating income was positive in three of the last eight fiscal years (2019, 2020, 2023) and negative in the other five — a cyclical pattern amplified by acquisition-related charges. The 2024 operating loss of -$227.0M was primarily driven by a $236M non-cash goodwill impairment on the STI Norland acquisition.

Cash flow (SEC EDGAR XBRL, verified):

Operating cash flow has been positive for four consecutive years through both an acquisition-write-off year and the 2024 revenue trough. However, the trend is declining: -$130M drop from the 2023 peak to 2025. Earlier cycle troughs (2020: -$122.2M; 2021: -$263.2M) show that OCF can turn sharply negative in a severe downturn.

Balance sheet (SEC EDGAR XBRL, verified):

Cash fell $118.6M in 2025, partly reflecting the APA Solar acquisition outflow. No going-concern language in recent filings. External data (not in XBRL): Series A redeemable perpetual preferred stock with ~$482M stated value plus ~$98.5M accrued dividends (~$580M total senior claim) and ~$445M in convertible notes ($345M due 2031 at 2.875% issued June 2025, plus ~$100M due 2028 at 1.00%).

Share count (SEC EDGAR XBRL, verified):

Mild dilution: ~20% share count increase over approximately six years (2020-2026), primarily from the STI acquisition in 2022. Rate has slowed significantly — essentially flat in 2023-2026 (+0.8M shares in three years). No buyback program.

Valuation

Current multiples: At $9.22/share and 152.8M shares, market cap is $1.386B. 2026 guided adjusted EBITDA of $200-230M (midpoint $215M) implies approximately 6x EV/EBITDA on a rough market-cap basis (cash of $244.4M partially offsets $445M+ of convertible debt; net debt is a modest positive). GAAP operating income was -$29.0M in FY2025, so no meaningful trailing P/E exists. Nextracker (Nextpower) trades at a meaningful premium on comparable metrics with approximately 2-3x ARRY's revenue.

Peer context: At ~6x 2026 guided adjusted EBITDA, ARRY is priced at a discount to Nextracker. The gap reflects: (1) execution risk on IRA-driven revenue, (2) preferred stock complexity subordinating common, (3) IRA post-2027 structural headwind, (4) prior STI write-down reducing capital-allocation credibility. Closing even half the NXT gap implies a stock in the $12-$14 range (8-9x guided adjusted EBITDA).

Fair-value range: $10-$13 per share.

Method: 2026 guided adjusted EBITDA midpoint $215M × 7-9x EV/EBITDA (discount to NXT's premium; reflecting IRA cliff risk and preferred complexity). 7x = bear case (IRA demand air pocket materializes, margins compress to 28%); 9x = base case (Q2-Q3 2026 converts at guidance, 45X credit continues, Treasury guidance confirms domestic content eligibility). At 7x: ~$1.5B EV, less ~$200M net debt, divided by 152.8M shares = ~$8.50 (below current). At 9x: ~$1.94B EV, less ~$200M net debt = ~$11.40 per share. Range brackets the analyst consensus (~$10 average) and UBS May 2026 target ($11). BofA's bear target ($7) represents the 5-6x multiple, full-miss scenario.

Ownership & Insiders

ARRY has broad institutional sell-side coverage — 26+ analysts from major banks including UBS (Buy, $11 PT), JPMorgan, Citigroup, and BofA (Underperform, $7 PT). The genuine disagreement between UBS and BofA reflects real controversy, not a pump scheme. No paid promotion signals identified.

Share count has grown modestly from 150.2M (2022) to 152.8M (2026) — mild dilution from equity compensation, not a structural issuance pattern. No active buyback program. The Series A preferred stock accretes and pays dividends that drain economic value from common holders; the preferred is perpetual and held by private investors.

Convertible notes ($345M at 2.875%, capped calls at $12.74/share effective dilution ceiling): at the current $9.22 price there is no in-the-money dilution risk, but any sustained rally above $12.74 triggers share issuance.

Short interest: 16.7% of float (Fintel/StockDetect, external). Elevated — reflects institutional skepticism centered on IRA risk, preferred complexity, and STI precedent.

Bull Case

ARRY's central bull case rests on three mutually reinforcing arguments that the current $9.22 price does not adequately price.

1. The orderbook is already contracted. A $2.4B orderbook (Q1 2026, management commentary via StockTitan) represents 18-24 months of revenue at the current run-rate. The majority of this backlog was contracted under pre-reconciliation-bill IRA economics and is largely grandfathered from the ITC/PTC phase-out. The IRA demand cliff falls on post-2027 new greenfield project starts, not on the existing contracted book. The record 2x Q1 2026 book-to-bill validates the pull-forward thesis: customers are actively front-loading orders to secure grandfathering, compressing the risk window.

2. The domestic content moat is genuinely widening. ARRY's Albuquerque facility delivers 100% domestic-content DuraTrack and OmniTrack — the only tracker manufacturer with this manufacturing profile. As IRA thresholds escalate to 50% (2026) and 55% (post-2026), rivals without US manufacturing face progressive exclusion from ITC/PTC domestic content bonuses. The 45X Advanced Manufacturing Production Credit on torque tubes is a direct gross margin tailwind not eliminated by the reconciliation bill — this is cash flowing into ARRY's P&L from federal tax credit policy that cannot easily be replicated by competitors without US facilities.

3. Cash generation is real. Operating cash flow was $101.8M in FY2025 and $154.0M in FY2024 despite a GAAP loss year in 2024 (-$240.4M, primarily the $236M non-cash STI write-off) and a partial GAAP loss in 2025 (-$52.2M). The write-off is done; the 2024 impairment charge does not repeat. At ~6x 2026 guided adjusted EBITDA, a partial re-rating toward Nextracker's multiple implies 30-50% upside from the current price without requiring multiple expansion beyond a still-discounted level.

Q1 2026 showed the margin recovery is intact: adjusted gross margin of 30.7% came in above the feared tariff-pressured 28-29% range, and the 2x book-to-bill is the highest in ARRY's public history.

Bear Case & Red Flags

1. IRA legislative cliff (HIGH severity) The One Big Beautiful Bill (passed Senate July 2025) phases out clean electricity ITC/PTC for new project starts: approximately 60% of prior level in 2026, 20% in 2027, and zero from 2028 onward. While the $2.4B orderbook is largely grandfathered, every new greenfield project starting construction after 2025 faces materially worse economics from 2027 and no federal credit from 2028 unless Congress acts. The record 2x Q1 book-to-bill may partly reflect a demand pull-forward that historically presages a sharp trough once front-loaded orders are exhausted. Management's own figures confirm the urgency is real — which is precisely the concern.

2. Preferred stock subordination (HIGH severity) Series A redeemable perpetual preferred stock carries approximately $482M stated value plus $98.5M accrued dividends, totaling ~$580M in senior claims above common shareholders (external filing data, not in XBRL). The preferred accretes and pays dividends. In Q1 2026, GAAP net loss to common was -$13.5M despite positive adjusted net income of +$9M — the gap is the preferred dividend drag. At a $1.386B market cap, common holders are effectively buying into a capital structure where more than 40% of enterprise value is senior to them at par, before they see any residual claim.

3. Demonstrated capital-allocation failure (MEDIUM-HIGH severity) ARRY acquired STI Norland in 2022 for approximately $400M+ (external, not in XBRL). The 2024 operating income of -$227.0M (fact sheet confirmed) was dominated by a $236M non-cash goodwill impairment plus $91.9M intangible write-down — a near-total write-off of a major acquisition made at cycle peak. The APA Solar acquisition ($179M, closed 2025) follows a similar pattern: bolt-on international expansion, non-trivial price, integration required. The ~50% APA orderbook growth in Q1 2026 is encouraging, but the STI precedent imposes a meaningful credibility discount on any ARRY acquisition thesis.

4. Tariff margin pressure (MEDIUM severity) BofA downgraded ARRY to Underperform ($7 target) citing India tariff increases (to 50%) and Mexico gearset tariffs (25%). Management trimmed full-year 2025 adjusted gross margin guidance to 28-29% from 29-30% as a result. ARRY passes approximately 75% of incremental tariff cost to customers but absorbs the rest. Q1 2026 adjusted gross margin of 30.7% was resilient, but tariff policy remains volatile and any escalation — particularly on steel/aluminum inputs — compresses margins during the precise window ARRY needs to demonstrate 30%+ durability.

5. Convertible note dilution ceiling at $12.74/share (MEDIUM severity) ARRY issued $345M of 2.875% convertible notes due July 2031 in June 2025, plus retains ~$100M of 1.00% convertible notes due 2028 (external data). Capped calls cap the net dilution ceiling at $12.74/share for the 2031 notes. Any sustained rally above $12.74 triggers share issuance against $345M+ principal. Combined fixed claims (preferred dividends + convertible interest) consume a significant portion of the $101.8M FY2025 operating cash flow.

6. Revenue cyclicality is structural (MEDIUM severity) Revenue from the fact sheet: $872.7M (2020), $853.3M (2021), $1,637.5M (2022), $1,576.6M (2023), $915.8M (2024), $1,284.1M (2025). The 2024 trough was a -44.1% collapse from the 2022 peak. Solar project timelines create lumpy multi-year booking and revenue recognition cycles; the 2028 IRA cliff introduces the next potential structural trough. At cycle troughs, operating cash flow has been deeply negative: -$122.2M (2020), -$263.2M (2021). A repeat of that pattern with $580M+ of senior preferred claims and $445M of convertible debt would be severe.

7. GAAP operating income negative in five of eight years (MEDIUM severity) GAAP operating income was positive in only three of the eight fiscal years in the fact sheet: FY2019 (+$83.4M), FY2020 (+$95.2M), and FY2023 (+$214.1M). It was negative in FY2018, FY2021, FY2022, FY2024, and FY2025. The single-year 2023 profitable period coincided with peak 45X credit flow and $1.577B revenue — a level not yet regained. GAAP net income was positive in four of eight years (adding FY2022's marginal +$4.4M). The adjusted-EBITDA narrative requires accepting substantial add-backs that have historically obscured real losses.

8. Declining operating cash flow trend (MEDIUM severity) OCF: $231.9M (2023), $154.0M (2024), $101.8M (2025) — a -56.1% decline over two years even as management presents an improving adjusted EBITDA outlook. Fixed obligations (preferred dividends, convertible interest) are growing while cash generation is shrinking. The trajectory must reverse for the preferred to remain comfortably serviceable without a liquidity event.

Interesting Findings

• The bear case in the research materials incorrectly stated that FY2023 was the "single profitable year" for GAAP common shareholders and that common holders received GAAP income "in effectively one year out of eight." The fact sheet confirms that GAAP operating income was positive in three of eight years (FY2019, FY2020, FY2023) and GAAP net income was positive in four of eight years (adding FY2022's +$4.4M). The bear's structural profitability argument is directionally valid — GAAP losses are more common than profits — but the "one year out of eight" framing overstated the historical loss record and has been corrected here.
• The 45X Advanced Manufacturing Production Credit (for torque tubes and structural fasteners) is mechanically different from the ITC/PTC. The reconciliation bill phased out the project-level ITC/PTC but did not eliminate 45X in the same manner. ARRY's gross margin tailwind from 45X is therefore a degree more durable than its project-economics tailwind — a genuine nuance the bull thesis correctly identifies.
• Share count has been essentially flat for four years: 150.2M (March 2022) to 152.8M (February 2026), a 1.7% increase over four years. The bulk of the total dilution since IPO (127.0M in 2021) occurred in the single year of the STI acquisition. Post-acquisition, dilution has been minimal. This is more favorable than a surface-level look at the absolute share count growth suggests.
• The STI goodwill impairment (-$236M in 2024) and intangible write-down (-$91.9M) are reflected in the 2024 operating income of -$227.0M (fact sheet confirmed). With these non-cash charges now written off, the 2025 operating loss of -$29.0M represents ARRY's underlying run-rate GAAP losses, which are far more manageable and narrowing toward breakeven as revenue scales.

The Read

Array Technologies is a genuine industrial business in a structurally sound market — the US utility-scale solar buildout is not speculative, the domestic content moat is real and compounding, and the operating cash flow track record is positive through a cycle trough. The problem is not the business fundamentals; it is the combination of a capital structure that subordinates common holders and a legislative cliff that creates a hard demand expiry date.

At $9.22 and ~6x 2026 guided adjusted EBITDA, the stock is pricing in a meaningful execution discount relative to Nextracker — arguably too much of one if the $2.4B orderbook converts as guided and 45X credit continues to flow. The near-term (2026-2027) picture is reasonably constructive: contracted revenue, domestic content tailwinds, and a record book-to-bill provide a cash-flow floor. The structural concern is the 2028+ demand cliff. If the reconciliation bill's ITC/PTC phase-out is not extended or replaced, new greenfield solar economics deteriorate materially from 2028, and the pull-forward that drove the 2x book-to-bill creates its own air pocket when exhausted.

For a buyer at this price, the thesis is essentially: the contracted orderbook funds cash flow through 2027, the 45X credit and domestic content moat maintain margin advantage, and post-2027 policy clarity emerges before the order pipeline empties. That is a reasonable bet — not a stretch — but it requires trusting management's execution on two fronts (APA integration and margin delivery) after a prior major acquisition ended in a $400M+ write-off.

The preferred stock is the structural complexity that reduces the margin of safety. At ~$580M senior to common equity, any scenario where operating cash flow dips below service requirements (as it did in 2020-2021) creates real pressure on the capital structure. That risk is not priced into the $9.22 stock price, and it is not fully captured by the adjusted-EBITDA multiple.

Research, not investment advice. Figures sourced from SEC filings and public data; verify before acting.